Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech FOA Q1 2026 Earnings Strong EPS Surprise Amidst Uncertain Revenue Outlook FGN Q1 2026 Earnings EPS Misses Analyst Estimates Amid Market Volatility DCOMP Q1 2026 Earnings EPS Misses Estimates Stock Flat SNOW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Gains Momentum TGEN Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher